Montai Therapeutics

Montai Therapeutics is an artificial intelligence company in Cambridge, United States, founded in 2019. It has raised $50.0M across 1 round, most recently a $50.0M Series A in December 2022.

A Flagship Pioneering Company

Headquarters
Cambridge
Employees
11–50
Founded
2019
Business Model
B2B
Website
montai.com
Total Funding
$50.0M
Last Round
$50.0M Series ADec 2022
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Montai Therapeutics is harnessing AI to decode untapped, diverse chemistry to develop breakthrough oral medicines that address persistent unmet needs in chronic disease. With its CONECTA platform, Montai has built foundation models for decoding the complex language between nature's bioactive chemistry and human biology, supercharging drug discovery with new optionality and predictability. Founded in 2019 as a Flagship Pioneering company and led by co-founder and CEO Margo Georgiadis, Montai is advancing a pipeline of first-in-class oral medicines targeting validated biological pathways in inflammation and immunology, including biologic replacements and historically difficult-to-drug transcription factors.

Summary

It lists 11–50 employees. It has raised $50.0M in total across 1 round, most recently a $50.0M Series A round in Dec 2022. Investors include Flagship Pioneering.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries ADec 2022
$50.0M

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Anthropic

Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...

San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+Total funding$123.7BMay 2026
xAI

xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

San Francisco, United States201–500Artificial Intelligence, Generative AI
Series ETotal funding$47.4BJan 2026
Waymo

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...

Mountain View, United States1001–5000Artificial Intelligence, Autonomous Vehicles
Venture RoundTotal funding$29.6BFeb 2026
Databricks

Databricks provides a unified data and AI platform that helps enterprises build and run applicati...

San Francisco, United States10001+Analytics, Artificial Intelligence
Series G+Total funding$20.0BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Montai Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/montai-therapeutics"><img src="https://indexed.vc/api/badge/company/montai-therapeutics" alt="Montai Therapeutics on Indexed.vc" width="260" height="76" /></a>